Rezultati pretraživanja
  1. Deciphera Pharmaceuticals Top stock up 251% from low. Close: 67.16 VolvsAvg: 0.74 Liq: $19M

  2. prije 5 sati
  3. here we go!! 4.17 % change recently

  4. 4. velj

    looks like your kind of setup here :)

  5. 4. velj

    nice weekly candle in the making. may test 70 soon.

  6. 3. velj
    Prikaži ovu nit
  7. 3. velj

    needs higher high

    Prikaži ovu nit
  8. 31. sij

    Hurting with one -3.28 % change recently

  9. 30. sij
    Prikaži ovu nit
  10. 30. sij

    or ? The 2 companies adopted different strategy for 2nd line : targets only PDGFa mutant, while all comers. I doubt data for all comers will be as impressive as the targeted approach. But target approach requires testing. Which one wins? I 👍

  11. 30. sij

    $7.50 Million in Sales Expected for Deciphera Pharmaceuticals Inc This Quarter

  12. 30. sij

    Patricia L. Allen Sells 25,000 Shares of Deciphera Pharmaceuticals Inc Stock

  13. 30. sij

    Deciphera Pharmaceuticals Inc Director Sells $1,653,250.00 in Stock

  14. 30. sij
    Odgovor korisnicima

    Unless you’re more geared as a buy and hold investor, I would cut losses (if you have any) and move on. Stocks that receive offerings rarely workout the way did after it’s offering last August.

  15. 30. sij

    interesting to see how , does tomorrow. similar to , except it’s still preclinical. looks like will be valued > $1b at open. precision medicine is the future.

  16. 29. sij
    Prikaži ovu nit
  17. 29. sij

    looks like a double top and possible head and shoulders forming. ⚠️ if no M and A

  18. 29. sij

    Deciphera Pharmaceuticals Inc Expected to Earn FY2024 Earnings of $6.49 Per Share

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.